483
National Marrow Donor Program IRBNational Marrow Donor Program IRB – FDA 483, Apr 4, 2023
Record Details
An FDA inspection of the National Marrow Donor Program IRB in Minneapolis, MN, revealed a significant deficiency in their review procedures. The Institutional Review Board improperly utilized expedited review for changes to previously-approved research protocols that were not minor in nature. This indicates a failure to adhere to appropriate review standards for research modifications.
View Company Profile
ID · bf9c3870-7d31-4559-85c4-8c293e741e77
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.